Biomarker Expression in Tissue Samples From Patients With Bone Sarcomas

NCT01807052 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 34

Last updated 2016-05-19

No results posted yet for this study

Summary

This trial studies biomarker expression in tissue samples from patients with bone sarcomas. Studying biomarker in tissue samples from patients with cancer in the laboratory may help doctors identify and learn more about biomarkers related to cancer

Conditions

  • Localized Osteosarcoma
  • Metastatic Osteosarcoma
  • Recurrent Osteosarcoma

Interventions

OTHER

laboratory biomarker analysis

Correlative studies

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH
  • Children's Oncology Group

    lead NETWORK

Principal Investigators

  • Mark Ranalli, MD · Children's Oncology Group

Eligibility

Max Age
39 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-11-30
Primary Completion
2016-05-31
Completion
2016-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01807052 on ClinicalTrials.gov